0000914475-15-000061.txt : 20150205 0000914475-15-000061.hdr.sgml : 20150205 20150205171830 ACCESSION NUMBER: 0000914475-15-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150203 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grigoriadis Dimitri E. CENTRAL INDEX KEY: 0001423838 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 15581138 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-02-03 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001423838 Grigoriadis Dimitri E. NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Research Officer Restricted Stock Unit 2015-02-03 4 A 0 11000 0 A Common Stock 11000 11000 D Stock Option 32.99 2015-02-03 4 A 0 65000 32.99 A 2025-02-03 Common Stock 65000 65000 D Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock. The Restricted Stock Units will vest annually at 1/4 of the units vesting on February 3, 2016, February 3, 2017, February 3, 2018 and February 3, 2019. Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 3, 2015 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Darin Lippolt, By Power of Attorney 2015-02-05 EX-24 2 lloydsmithpoa.htm LIMITED POWER OF ATTORNEY

LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE





 The undersigned, as an Officer of Neurocrine Biosciences, Inc. (the "Corporation"),

hereby constitutes and appoints, jointly and severally Kevin C. Gorman, Timothy P. Coughlin

and Darin Lippoldt, each of them, the undersigned's true and lawful attorney-in-fact and agent,

each with the power of substitution for her in any and all capacities to complete and execute such

Forms 144, advisable pursuant to Rule 144 promulgated under the Securities Act of 1933 (as

amended) and Forms 3, 4, and 5 advisable pursuant to section 16 of the Securities Exchange Act

of 1934, and other forms as such attorney shall in his or her discretion determine to be required

by the rules and regulations promulgated thereunder, or any successor laws and regulations, as a

consequence of the undersigned's ownership, acquisition or disposition of securities of the

Corporation, and to do all acts necessary in order to file such forms with the Securities and

Exchange Commission, any securities exchange or national association, the Corporation and

such other person or agency as the attorney shall deem appropriate.  The undersigned hereby

ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by

virtue hereof.



 This Limited Power of Attorney is executed at San Diego, California, as of the date set

forth below.





       __________________________________

       (Signature) Malcolm Lloyd-Smith



      Date:  12/18/14